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Abstract 
Background: Increasing reports of Vancomycin resistance have raised concerns about effectiveness of this 
drug. One of the most important factors of resistance emergence is no adherence of physician to principles of 
antibiotic therapy. This study is a drug utilization evaluation (DUE) of Vancomycin in pediatric ward to assess 
appropriateness of drug regimens and to find possible problems in clinical practices that may necessitate 
reconciliation to improve Vancomycin use. 
Materials and Methods: This prospective study was done for 1year from October 2014 to September 2015 at 
Khalij Fars General Hospital in Bandar Abbas. Data including patients’ demographics, paraclinic, diagnosis, 
vancomycin dose, and treatment duration were collected. The concordance of practice with standard guidelines 
(CDC, ASHP, and IDSA) and principles of antibiotic therapy was assessed. Results were analyzed by SPSS 20. 
Results: 102 medical records were reviewed in this study. Pneumonia (60=59%) and sepsis (22=21.5%) were 
the most common diagnosis. Sampling was done in 6% of patients with 2% antibiogram. Vancomycin was 
administered appropriately in 56.9% percent of patients with no sex difference (PV= 0.55) but age with 
significant difference (PV= 0.017). Over use was in a great proportion of patients (36cases=35%) as 
unnecessary, improper combination and broad spectrum regimen. 
Conclusion: Vancomycin was overused irrationally in a great proportion of patients. There was no serum level 
monitoring. Microbial resistance, serum trough level monitoring programs and continuous medical education 
for physicians can be effective in rational use of antibiotic. 
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Introduction 
The majority of admitted inpatients are given 
antimicrobials as therapy or prophylaxis during their 
hospital stay. It has been shown that at least fifty 
percent of antimicrobial prescriptions are unnecessary. 
These irrational uses are due to inappropriate 
prophylactic antimicrobial prescribing, staying on 
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empiric therapy in a stable patient without positive 
cultures, and no information about susceptibility 
patterns of common pathogens. Antimicrobial over 
prescription increases the costs of health care, arise 
super infection due to antimicrobial-resistant 
bacteria, as opportunistic fungi, and may raise the 
likelihood of an unwanted drug side-effects. On the 
other hand, no consumption in an urgent condition at 
the bedside may also result to critical results. 
Antibiotics should be used as guidelines only and 
sometimes changed pursuant to medical judgment 
relative to individual patient needs1. Vancomycin has 
a narrow and specific antibacterial spectrum against 
Methicillin resistant Staphylococcus aureus (MRSA), 
penicillin resistant S.pneumonia and resistant 
entrococcus infections and is saved for this serious 
and constantly growing public health concerns2-4. 
Also secondary resistance to vancomycin use is an 
important challenge5. Drug utilization evaluation has 
been found as an effective method to further 
interventions that will approve treatment outcomes 
and cost-effectiveness of the drug therapy6 and it is 
more important to control rational use of antibiotic to 
prevent resistance by continuing medical education 
(CME) course7. To achieve this target, true antibiotic 
selection consistent with guideline criteria and right 
through concentration are required8. We conducted 
this drug utilization evaluation (DUE) study in 
pediatric ward to determine rate of rational use of 
Vancomycin according to the standard guidelines. 
The rate of positive culture and antibiogram are low 
and therapeutic regimens are usually syndrome based 
and notifying patient’s host factors. It is necessary to 
understand defects in Vancomycin use to find a 
solution and save this highly valued antibiotic for 
common perilous infections by resistant 
Staphylococcus and Pneumococcus with other less 
effective and expensive treatments. 
Methods 
This prospective study was carried out to evaluate the 
utilization of vancomycin from October 2014 to 
September 2015 in one year as census on all pediatric 
patients who received vancomycin. The study was 
conducted in Khalij Fars Hospital, a general hospital 
with 255 beds including 25 pediatric and 10 NICU 
ones in Bandar Abbas. Vancomycin administration 
was assessed according to CDC, ASHP and IDSA 
guidelines. Predesigned data collection form was 
implemented in this study including sex, age, weight, 
creatinine, CBC, platelet, diagnosis, microbiological 
culture/sensitivity testing and occurrence of adverse 
drug reaction as hearing loss, tinnitus, renal failure, 
thrombocytopenia, co-administered antibiotics, 
vancomycin dose, result of treatment, infectious 
disease specialist consultation. Vancomycin utilization 
was evaluated by a pediatric specialist, a neonatologist 
and a pediatric infectious disease subspecialist. 
Glomerular Filtration Rate (GFR) was calculated for 
all patients using Cockroft-Gualt formula as an 
estimation of creatinine clearance. Results were 
reported as appropriate and inappropriate use due to 
dose per kg of body weight based on renal function 
tests, initial platelets count, diagnosis, culture and 
antibiogram, concurrent diseases and drugs as A: 
Appropriate, B:Inappropriate, (B1:Unnecessary,  
B2:Age, B3:Concomitant Disease, B4:Insufficient Spectrum, 
B5-1:Low Broad Spectrum,  B5-2:High Broad Spectrum, B5- 
3:Unnecessary Combination of Two Similar Spectrum 
Antibiotic, B5-4:Ineffective, B6-1:Low Dose, B6-2: High Dose, 
B7:Improper Combination, B8-1: Short Duration, B8-2:Long 
Duration. Dose difference more than 20% was 
considered as incorrect dose. The serum 
concentrations of vancomycin were not measured. 
(Not available). Information was collected and data 
were analyzed using SPSS 20 software. 
Results 
During 12 months of study period, 102 patients (46 
males and 56 females without significant difference, P 
value= 0.55) received Vancomycin. The age of 
patients are showed in Table 1. Diagnosis was made 
mostly by clinic and imaging and lesser with other 
paraclinical techniques as Table 2. Number and 
percent of appropriate (58cases=56.9%) and 
inappropriate (44cases=43.1%) use of Vancomycin 
based on studied factors are shown in Table 3. 
Appropriateness of vancomycin use based on culture 
with antibiogram and syndrome treatment are shown 
in Table 4. There was significant difference in 
appropriateness of vancomycin use in three group 
based on age (Neonate, Infant, Child) (P value= 
0.017). The most appropriate use was in 29day-24 
months (68.1%) and the least in 2-13 years (20%) 
(Table5). The main reasons of vancomycin 
administration were pneumonia (60 cases=59%) and 
sepsis (22cases=21.5%) in order, and other diagnosis 
as Table 6. All patients were given combination 
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therapy of vancomycin with one to five other 
antibiotics including Amikacin, Gentamicin, 
Ceftriaxon, Cefotaxim, Ceftazidim, Meropenem, 
Ampicillin, Piperacillin-Tazobactam, Clindamicin, 
Metronidazole. Final result of treatment based on 
appropriateness of vancomycin use is shown in table 
7. Therapeutic monitoring of serum vancomycin 
concentrations was not available. There was no 
prophylactic use. No regimen was prescribed with 
pediatric infectious disease subspecialist 
consultation. 
Discussion 
The project work involves the drug utilization 
evaluation of vancomycin in a pediatric ward 
regarding diagnosis, culture results and host factors. 
In 102 studied patients, 46 males and 56 females 
received Vancomycin relatively equal in both as it is 
expected. Vancomycin has a narrow spectrum for 
special microorganisms with no sex predominance. 
All prescriptions were therapeutic. Only 6% had 
positive culture with 2% antibiogram. Near to total 
received vancomycin empirically, a finding more 
than commonly observed in other studies in adults in 
range of 69-79%7, 9-11, and similar in pediatric as 
following studies. Saker reported vancomycin 
exposure rates for first evaluations of late-onset 
sepsis are high in very low birth weight infants as 
60% based on having one or more positive blood 
cultures or receiving empiric vancomycin12. 
Infections with organisms necessitating vancomycin 
treatment usually are serious and life-threatening 
diseases with very low to no chance waiting for 
culture and antibiogram results. Prescriptions were 
usually based on syndrome diagnosis and 
epidemiologic factors. Appropriateness of vancomycin 
use based on culture with antibiogram and syndrome 
treatment were reversed but this cannot be relied 
because of low number of cultures. In our study 
Vancomycin was used appropriate in 58 cases (57%) 
based on CDC, ASHP and IDSA guidelines and 
inappropriate in 44 cases (43%) in pediatric ward. In 
Oliveira study out of 118 vancomycin prescriptions, 
95 (80.5%) were considered appropriate. Appropriate 
use was based on empiric therapy with risk factors, 
treatment of proven Gram-positive infections and 
Beta-lactam allergy; inappropriate use was based on 
empiric therapy without risk factors and continued 
empiric use without further evidence of Gram-positive 
infection in pediatric and adult patients overall without 
separating and analyzing13. An evaluation of antibiotic 
prescription pattern based on DDD counting showed 
high use of essential drugs of vancomycin and 
imipenem by defined daily dose calculation in patients 
0.5 to 96 years. This was partly due to type of patient’s 
disease (heart surgery) and party due to lack of 
sufficient knowledge about common antibiotic 
Table 2: Diagnostic Methods used in patients receiving Vancomycin. 
Percent Number Diagnostic Method 
12.7 13 Clinical 
4.9 5 Clinical + Culture 
79.4 81 Clinical + Radiology 
2 2 Clinical + Radiology + Sonography 
1 1 Clinical +Culture + Radiology + Sonography + CT Scan  
100 102 Total 
 
 
Table 1: Number and percent of patients receiving 
Vancomycing based on age. 
Percent Number Age 
%44 45 0 –   28   Days 
%46 47 29D-24   Month 
%10 10 2 –   13   Year 
%100 102 Total 
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resistance objects in hospital14. Al Za’abi from Oman 
reported 79.1 % inappropriate use of vancomycin 
based on HICPAC guidelines in adult and pediatric 
patients. This was mainly due to the continuous use of 
vancomycin following negative microbiological 
cultures for β-lactam-resistant Gram-positive 
microorganisms. Therapeutic drug monitoring (TDM) 
practices did not comply with recommendations on the 
use of trough concentration in the specified range as a 
guide for monitoring of therapy15.  
In this study there was inappropriate indication and 
unnecessary use in 14% of cases. Fahimi study in one 
year showed inappropriate indication and dosing 
regimen of vancomycin in 97.7% of adult and 
pediatric cases. The most use of vancomycin was 
recorded in hematology – oncology ward mostly as 
empirical and Intensive Care Unit (ICU). Culture 
responses were negative despite great clinical evidence 
of infection16. In Salehifar study considering the 
indication, Vancomycin was administered 
appropriately in 58 percent of adult patients9. In 
Wendy study, utilization of vancomycin was 
appropriate in 98% of patients in a Pediatric 
Emergency Department based on admitting 
diagnosis17. A retrospective drug utilization evaluation 
in pediatric patients who received intravenous 
vancomycin, 64.6% and 89.6% courses were 
consistent with guidelines for indication of therapy 
and dosing regimen in order18. Megan Bollinger 
reported four main reasons of inappropriate use of 
vancomycin in patients 8 days to 93 years including 
below-target dosing, short duration of use, inadequate 
monitoring of serum trough levels (72% sub 
therapeutic serum levels) and low blood cultures done 
(65.6% of cases)19.  
In Askarian study in Shiraz on both children and adult, 
of the 200 patients, 92% were prescribed the 
appropriate vancomycin dose and 51.5% received the 
appropriate duration of treatment. In 6.0% of the 
patients the prescription of vancomycin was 
appropriate according to HICPAC guidelines20. In this 
Table 3: Number and percent of appropriate and 
inappropriate use of Vancomycin based on studied 
factors. 
Percent Number Appropriateness 
56.9 58 A 
43.1 44 B 
13.7 14 B1 
0 0 B2 
0 0 B3 
0 0 B4 
0 0 B5-1 
2 2 B5-2 
2.9 3 B5-3 
1 1 B5-4 
0 0 B6-1 
0 0 B6-2 
8.8 9 B7 
6.9 7 B8-1 
1 1 B8-2 
2.9 3 B5-2, B5-3, B7 
2 2 B7, B8-2 
1 1 B5-3, B7 
1 1 B5-2, B1 
100 102 Total 
B1:Unnecessary, B2:Age, B3:Concomitant Disease, 
B4:Insufficient Spectrum, B5-1:Low Broad Spectrum,  
B5-2:High Broad Spectrum, B5- 3:Unnecessary 
Combination of Two Similar Spectrum Antibiotic, B5-
4:Ineffective, B6-1:Low Dose, B6-2: High Dose, 
B7:Improper Combination, B8-1: Short Duration, B8-
2:Long Duration 
 
Table 4: Number and percent of appropriate and inappropriate use of Vancomycin based on Antibiogram. 
Total     Inappropriate Appropriate         Appropriateness 
 Percent No Percent No Percent No 
6% 6 4.1% 4 1.9% 2 With Antibiogram 
94% 96 39% 40 55% 56 Without Antibiogram 
10% 102 43.1% 44 56.9% 58 Total 
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study the most common reason of inappropriate use 
was unnecessary use in 13.7% followed by improper 
combination, short duration, as 8.8%, 6.9% in order, 
incorrect combination of two similar spectrum 
antibiotic, concurrent high broad spectrum, 
ineffective, long duration and insufficient spectrum 
each in 1- 3% of cases and totally in 6 to 14% 
different combination of errors. Overall irrational use 
of vancomycin is due to high consumption with 
different errors. Many studies measured antibiotics 
usage with DDDs number. This is a DUE of 
Vancomycin regarding host factors. There was no 
fault in prescribing related to weight and renal 
function and no contraindication of starting and 
continuing vancomycin by drug side effect as 
thrombocytopenia and others. Appropriateness of 
drug administration cannot be compared based on 
diagnosis because of unequal number of diseases. 
Outcome was 1.5 to 2 times better in appropriate than 
inappropriate use. Therapeutic monitoring of serum 
vancomycin concentrations was not available which 
may cause missing sub therapeutic levels of the drug 
and usefulness. A very low positive culture also is an 
important factor in improper prescription of the drug. 
Conclusion 
Drug utilization evaluation is best criterion for 
assessing the clinical appropriateness and effective use 
of a drug. Rational use of antibiotics lowers 
emergence of resistance. These results showed the 
need to strengthen measures of drug use control. No 
restriction policy is suggested. Improving 
microbiologic cultures, investigation of Vancomycin 
serum levels and simultaneous continued medical 
education for antimicrobial decisions hence would 
lower empirical and raise rational use rate. 
Table 5: Number and percent of appropriate and inappropriate use of Vancomycin based on age. 
Total Inappropriate Appropriate Appropriateness 
Age    Percent Number Percent Number Percent Number 
100 45 46.7 21 53.3 24 1 – 28 day 
100 47 31.9 15 68.1 32 29day - 24 Month 
100 10 80 8 20 2 2 – 13  Year 
100 102 43.1 44 56.9 58 Total 
 
 
Table 6: Number and percent of appropriate and inappropriate use of Vancomycin based on diagnosis. 
Inappropriate Appropriate             Appropriateness 
Diagnosis % No % No 
35 21 65 39 Pnemonia 
50 11 50 11 Unknown Origin Sepsis 
100 3 0 0 UTI 
100 1 0 0 Meningitis 
100 2 0 0 Gastroenteritis 
50 1 50 1 Bronchiolitis 
0 0 100 2 Lymphadenopathy 
100 1 0 0 BPD1 
50 1 50 1 Umbilical Cord Inf. 
0 0 100 1 
NEC2, Premature 
0 0 100 1 
Intestinal Atresia 
100 1 0 0 Asthma 
100 1 0 0 Shigellosis 
0 0 100 1 Hirschsprung’s disease  
100 1 0 0 Sickle Cell Anemia 
0 0 100 1 Metabolic Dis. 
43.1 44 56.9 58 Total 
1BPD: Bronchopulmonary Dysplasia,2NEC: Necrotizing Enterocolitis 
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